Gene Expression Analysis Market worth $4.3 Billion by 2018

1
MarketsandMarkets Presents
Gene Expression Analysis Market worth 4.3
Billion by 2018
2

• According to the new market research report,
  Gene Expression Analysis Market by Technology
  (DNA Microarray, Real-Time PCR, Next Generation
  Sequencing), Consumables (DNA Chips, Reagents),
  Services (Gene Profiling, Bioinformatics, Data
  Analysis Software) Applications - Global
  Forecast to 2018 ,
• Browse 72 market data tables and 20 figures
  spread through 227 pages and in-depth TOC on
  Gene Expression Analysis Market by Technology
  (DNA Microarray, Real-Time PCR, Next Generation
  Sequencing), Consumables (DNA Chips, Reagents),
  Services (Gene Profiling, Bioinformatics, Data
  Analysis Software) Applications - Global
  Forecast to 2018.
• http//www.marketsandmarkets.com/Market-Reports/ge
  ne-expression-analysis-market-156613968.html

3

Early buyers will receive 10 customization on
Reports.
4

• The Global Gene Expression Analysis Market
  (2013-2018) analyzes and studies the major
  market drivers and restraints in North America,
  Europe, Asia, and the Rest of the World (RoW).
• Global gene expression analysis market estimated
  at 2.6 billion in 2013 and is expected to reach
  4.3 billion by 2018, growing at a CAGR of 10.4
  from 2013 to 2018.
• This report covers the definition, description,
  and forecast of the global market in terms of
  instrumentation, consumables, services, and
  applications. Based on technology, the gene
  expression analysis instrumentation market
  comprises DNA microarrays, real-time PCR,
  next-generation sequencing, and others. The
  consumables market is categorized into DNA chips
  and reagents, while the services market is
  further sub-segmented into gene expression
  profiling services, bioinformatics solutions,
  data analysis software, and others.

5

• North America dominated the global market,
  followed by Europe and Asia. The continued
  developments in the North American market are
  triggered by the increase in funding, to address
  the growth in the number of cancer patients. Asia
  is expected to grow at the highest CAGR. This can
  be attributed to the presence of high-growth
  markets such as India and China, improved funding
  scenario in this region, increasing number of
  conferences and exhibitions on gene expression,
  and increased focus on cancer research.
• Life Technologies (U.S.), QIAGEN N.V.
  (Netherlands), Illumina, Inc. (U.S.), Roche
  Diagnostics (Switzerland), Bio-Rad Laboratories,
  Inc. (U.S.), Agilent Technologies (U.S.),
  Affymetrix, Inc. (U.S.), GE Healthcare (U.K.),
  Thermo Fisher Scientific (U.S.), PerkinElmer,
  Inc.

6
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
7
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets